FMR LLC 13D and 13G filings for Agios Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-09-12 11:13 am Sale | 2022-09-09 | 13G | Agios Pharmaceuticals, Inc. AGIO | FMR LLC | 2,007,111 3.661% | -3,427,202 (-63.07%) | Filing |
| 2022-02-09 09:09 am Sale | 2022-02-08 | 13G | Agios Pharmaceuticals, Inc. AGIO | FMR LLC | 5,434,313 10.006% | -2,199,667 (-28.81%) | Filing |
| 2021-03-10 09:46 am Purchase | 2021-03-09 | 13G | Agios Pharmaceuticals, Inc. AGIO | FMR LLC | 7,633,980 10.968% | 3,295,314 (+75.95%) | Filing |
| 2021-02-08 10:15 am Sale | 2021-02-05 | 13G | Agios Pharmaceuticals, Inc. AGIO | FMR LLC | 4,338,666 6.264% | -204,140 (-4.49%) | Filing |